semaglutide online india Generic shot available for Rs 1,296 per month: Top diabetologists welcome cost cut with a word of caution Weight-loss jab could be made

Managing stress through breathing exercises or mindfulness reduces visceral hypersensitivity that can amplify nausea perception

Food and Drug Administration (FDA) officially approved Zepbound (tirzepatide) injection, under the brand name Mounjaro for chronic weight management in 2023

Other potential side effects can include decreased appetite, fatigue, and injection site reactions

Phase Phase 2 Early maintenance Weeks Weeks 58 Dose 5 mg once weekly Notes First true maintenance dose

Find out which is right for you We understand that everyones weight loss journey is different and what works for one person, may not be right for another

doi: 10.1002/9780470316696 [DOI] [Google Scholar] 20.Henry L, Wickham H